Chemplast Sanmar Limited DCF Valuation

CHEMPLASTS · Chemicals · Current price ₹214.5

Full stock page
DocStoX fair value
₹185
low confidence · 37/100
Current price
₹171
Upside to fair value
+8.0%
Estimate range
₹167 – ₹204
Cash-flow model
₹185
Discounted cash flow (2-stage) · 60% weight
5Y profit growth
—
Model it yourself — DCF Calculator
Opens pre-filled with Chemplast Sanmar Limited's latest numbers.

Chemplast Sanmar Limited cash-flow valuation

Our discounted cash flow (2-stage) values Chemplast Sanmar Limited at ₹185 per share. Intrinsic value from 2-stage discounted cash flows (primary for asset-light / normal businesses); FCFE path. It carries 60% of the weight in our published estimate of ₹185. A discounted cash flow is only as good as the cash-flow path it assumes, so the assumptions behind it are listed in full below.

Try your own assumptions

Prefer to build the discounted cash flow yourself? The DCF calculator below opens pre-filled with Chemplast Sanmar Limited's reported free cash flow, net debt and share count, so you can set your own growth and discount rate.

How we got this fair value

Every number below is part of the same estimate for Chemplast Sanmar Limited. Nothing here is a target price or a forecast of where the share price will go.

Low confidence37/100

The inputs are thin or the models disagree sharply. This is our least reliable kind of estimate, so read the range rather than the single number.

Estimate range ₹167 – ₹204

Why this method for this business

The company operates in the specialty chemicals sector, which is a subset of the commodities sector. EV/Sales is appropriate for revenue-driven businesses with stable cash flows, while DCF is suitable for assessing intrinsic value based on discounted cash flows.

The models behind the number

Each method is weighted by how well its inputs held up for this company.

Discounted cash flow (2-stage)
₹18560% weight

Intrinsic value from 2-stage discounted cash flows (primary for asset-light / normal businesses); FCFE path

EV / Sales(not enough data)

required inputs missing

  • Discounted cash flow (2-stage) was already used but EV/Sales provides a complementary valuation lens for revenue-based businesses.

What was missing

  • Lack of forward EPS data for normalization
  • Limited analyst coverage for EV/Sales model

What drives it

12 inputs, grouped by how strong each claim is
ReportedRead from filings or market data. Verifiable, not our opinion.
FCF_0 (normalized)
269.5 ₹cr

fcf_norm (median ≤5y positive)

Net debt
1,952 ₹cr

gross debt (cash n/a)

MacroEconomy-wide input, not company-specific.
Discount rate (r)
15.53%

COE (building-block)

Beta
1.15

bottom-up industry

AssumptionA forward input the model chose. Reasonable people can disagree here.
Stage-1 start growth
8%

lifecycle-floor

Fade shape
linear

lifecycle Turnaround

Terminal growth (g)
4.86%

macro terminal × quality premium

Stage-1 years
8 y

lifecycle Turnaround horizon

JudgementOur read of the evidence, not a measurement.
Lifecycle stage
Turnaround

forecast engine (L20)

Quality premium
0.972×

moat None + capital allocation

DerivedFalls out of the inputs above: a model output, not an independent input.
Path
FCFE

computed (D/E vs 0.8)

Terminal-value fraction
0.47

PV_TV / (PV_1+PV_TV)

Who computed this

A language model (qwen3:8b) selects the valuation method and the judgement inputs for Chemplast Sanmar Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.

Estimated 15 Sept 2026. Re-run as new financials and news arrive.

How we value stocks

We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.

Read the full fair-value methodology

More on Chemplast Sanmar Limited

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.